Friday - December 27, 2024

2-Azaspiro[3.4]octane Derivatives as M4 Agonists

2024-10-22

ALEXANDRIA, Virginia, Oct. 22 -- NOVARTIS AG, Basel, Switzerland has been assigned a patent (No. US 12122761 B2, initially filed Dec. 6, 2022) developed by thirteen inventors Amy Calhoun, Cambridge, Massachusetts; Xin Chen, Lexington, Massachusetts; Kevin Matthew Gardinier, Arlington, Massachusetts; Edward Charles Hall, Boston, Massachusetts; Keith Jendza, Boston, Massachusetts; Nancy Labbe-Giguere, Arlington, Massachusetts; James Neef, Stow, Massachusetts; Daniel Steven Palacios, Cambridge, Mas . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

2-Azaspiro[3.4]octane Derivatives as M4 Agonists

Information Request Form

Copyright Targeted News Service 2024